CARA Stock Continues to Rise: Reasons to Watch This BioTech Stock
A biotechnology company firmly on the radar is Cara Therapeutics (NASDAQ:CARA). The US-based drug developer was recently successful in its trialing of lead candidate Korsuva. At the end of May, CARA stock popped as the ... [Read]